Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ProKidney Corp. - Class A Ordinary Shares (NQ: PROK )

1.800 -0.010 (-0.55%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 358,601
Open 1.770
Bid (Size) 1.670 (1)
Ask (Size) 1.910 (15)
Prev. Close 1.810
Today's Range 1.710 - 1.890
52wk Range 1.120 - 14.19
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer
Former CEO of Africa Healthcare Network brings extensive understanding of kidney disease to ProKidney 
From ProKidney
Via GlobeNewswire
7 Penny Stocks With Low Floats and High Short Interest
Is the 'smart money' on the money shorting these low-float penny stocks, or is there the opportunity for a short squeeze? Let's find out. 
Via InvestorPlace

Performance

YTD
-73.80%
-73.80%
1 Month
+12.50%
+12.50%
3 Month
-78.44%
-78.44%
6 Month
-84.00%
-84.00%
1 Year
-82.95%
-82.95%

More News

Read More
ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference
From ProKidney
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Is Chamath Palihapitiya Giving Up on ProKidney (PROK) Stock?
Via InvestorPlace
Why Shares of ProKidney Were Dropping Thursday
Via The Motley Fool
Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
ProKidney Reports Third Quarter Financial Results
From ProKidney
Via GlobeNewswire
ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates
From ProKidney
Via GlobeNewswire
ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2023
From ProKidney
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
PTC Therapeutics, Planet Fitness, Kemper And Other Big Stocks Moving Lower On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference
From ProKidney
Via GlobeNewswire
3 Biotech Stocks Due for a Massive Short Squeeze
Via InvestorPlace
ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights
From ProKidney
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023
Via Benzinga
ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC
From ProKidney
Via GlobeNewswire
ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization
From ProKidney
Via GlobeNewswire
Affirm Holdings, Applied Digital And Other Big Stocks Moving Lower On Thursday
Via Benzinga
ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC
From ProKidney
Via GlobeNewswire
ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference
From ProKidney
Via GlobeNewswire
ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights
From ProKidney
Via GlobeNewswire
ProKidney to Present at the BofA Securities Health Care Conference 2023
From ProKidney
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.